Group 1: Company Overview - Jiangsu Xinhang New Materials Co., Ltd. is listed under stock code 301076 [1] - The investor relations activity took place on May 18, 2023, from 10:00 to 11:00 [2] Group 2: Market and Product Insights - Major domestic and international PEEK manufacturers include Victrex, Solvay, Evonik, and others, with significant production capacities [3] - The demand for DFBP is expected to increase due to the expansion of PEEK applications and production capacities [3] Group 3: Product Quality and Pricing - DFBP quality directly impacts PEEK performance, affecting downstream applications [3] - Product price fluctuations are influenced by raw material costs and market competition, with gross margins affected by supply-demand dynamics and pricing strategies [3] Group 4: Production Capacity and Utilization - New production lines for DFBP are currently undergoing trial production, with customer validation in progress [3] - The company has three production lines in its fundraising projects, allowing for flexible product switching with minimal downtime [4] Group 5: Market Potential and Future Developments - The market for HAP products is expanding, primarily in high-end skincare products, with plans for further customer engagement post-capacity expansion [4] - The company aims to leverage its technology for future expansions in engineering plastics, cosmetics, and photoinitiators [4]

江苏新瀚新材料股份有限公司 2023 年第一季度报告 证券代码：301076 证券简称：新瀚新材 公告编号：2023-030 江苏新瀚新材料股份有限公司 2023 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、 误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息 的真实、准确、完整。 3.第一季度报告是否经过审计 □是 否 1 江苏新瀚新材料股份有限公司 2023 年第一季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □是 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | --- | --- | --- | --- | | | | | （%） | | 营业收入（元） | 112,533,633.36 | 99,059,468.01 | 13.60% | | 归属于上市公 ...

证券代码：301076 证券简称：新瀚新材 公告编号：2023-023 江苏新瀚新材料股份有限公司 二、参加人员 公司董事长、总经理严留新先生，财务总监王忠燕女士，董事会秘书李翔飞先 生，独立董事黄和发先生，保荐代表人陈春芳女士（如遇特殊情况，参会人员可能 进行调整）。 江苏新瀚新材料股份有限公司（以下简称"公司"或"新瀚新材"）已于 2023 年 2 月 18 日 在 中 国 证 监 会 指 定 的 创 业 板 信 息 披 露 网 站 巨 潮 资 讯 网 （www.cninfo.com.cn）上披露了《2022 年年度报告》及《2022 年年度报告摘要》。 为便于广大投资者进一步了解公司 2022 年年度报告和经营情况，公司定于 2023 年 3 月 9 日（星期四）下午 15:00 至 17:00 时，在"价值在线"（www.ir-online.cn）举 办新瀚新材（301076）2022 年度业绩说明会，与投资者进行沟通和交流，广泛听取 投资者的意见和建议。 一、说明会召开的时间、地点和方式 会议召开时间：2023 年 3 月 9 日（星期四）15:00-17:00 会议召开地点：价值在线（www.ir ...

Financial Performance - The company's operating revenue for 2022 was ¥398,088,103.44, representing a 16.39% increase compared to ¥342,031,413.67 in 2021[21]. - The net profit attributable to shareholders for 2022 was ¥106,946,897.04, a significant increase of 61.32% from ¥66,294,263.47 in 2021[21]. - The net cash flow from operating activities reached ¥132,151,014.95, marking a 74.89% increase from ¥75,560,864.86 in the previous year[21]. - Basic and diluted earnings per share for 2022 were both ¥1.03, up 30.38% from ¥0.79 in 2021[21]. - Total assets at the end of 2022 amounted to ¥1,252,731,396.32, a 14.51% increase from ¥1,093,960,706.38 at the end of 2021[21]. - The net assets attributable to shareholders increased by 6.72% to ¥1,081,405,604.96 at the end of 2022, compared to ¥1,013,272,465.60 at the end of 2021[21]. - The company's gross profit for 2022 was ¥14,376,840, reflecting a year-on-year increase of 31.33%[82]. - The company maintained a gross margin of 36.11% in 2022, up by 4.11 percentage points from the previous year[87]. - Revenue from specialty engineering plastic raw materials reached ¥202,824,425.47, a significant increase of 56.53% from ¥129,578,133.48 in the previous year[85]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 6 RMB per 10 shares to all shareholders, based on a total of 103,480,000 shares[5]. - The company reported a total shareholding of 20,340,000 shares at the beginning of the period, with an increase of 6,102,000 shares and a decrease of 2,000 shares, resulting in an ending total of 26,440,000 shares[169]. - The company held its annual general meeting with a 75.00% investor participation rate on May 17, 2022, approving multiple key resolutions[166]. Market and Competitive Position - The company is focused on expanding its market presence and developing new products and technologies to enhance its competitive edge[4]. - The company reported a significant increase in user data, reflecting a growing customer base and market demand for its products[4]. - The company is actively exploring potential mergers and acquisitions to accelerate growth and market expansion[4]. - The company has established long-term cooperative relationships with major global manufacturers in the PEEK field, enhancing its market competitiveness and sustainable development[38]. - The company is the exclusive supplier of HAP products to SYMRISE in China, indicating a strong partnership and market position[48]. Research and Development - The company has established cooperative research relationships with top domestic institutions, enhancing its continuous research and innovation capabilities[61]. - The company has increased its R&D investment to enhance existing product processes and develop new products with market potential[130]. - The R&D investment amount for 2022 was ¥13,325,241.33, representing 3.35% of operating revenue[98]. - Research and development expenses increased by 22.18% compared to the previous year, indicating a strong focus on innovation[82]. Risk Management - The company acknowledges risks including uncertainties from COVID-19, market competition, rising raw material costs affecting gross margins, and potential delays in new projects[4]. - The company emphasizes the importance of understanding the difference between plans, forecasts, and commitments, urging investors to be aware of investment risks[4]. - The company faces risks from fluctuating raw material costs and market competition, which may impact gross margins; it plans to establish long-term supplier relationships to mitigate these risks[139]. - The company is aware of the potential risks associated with new projects not generating expected benefits and plans to improve operational efficiency to ensure timely project success[141]. Corporate Governance - The company has established a sound corporate governance structure, enhancing operational compliance and decision-making processes[150]. - The board of directors consists of 9 members, including 3 independent directors, and held seven meetings, adhering to legal and regulatory requirements[153]. - The company emphasizes respect for stakeholders' rights and actively engages in corporate social responsibility initiatives[155]. - The company strictly adheres to information disclosure obligations in accordance with relevant laws and regulations, ensuring equal access to information for all shareholders[156]. Environmental and Social Responsibility - The company is dedicated to environmental and social responsibility as part of its long-term strategy[4]. - The company emphasizes environmental protection and safety management, implementing comprehensive management systems to ensure compliance with regulations[140]. Future Outlook - The company’s future outlook includes strategic initiatives aimed at improving operational efficiency and profitability[4]. - The company plans to increase its aromatic ketone production capacity from 4,200 tons/year to 12,200 tons/year over the next 2-3 years, with an additional 8,000 tons funded through capital raising[133]. - The company intends to strengthen its presence in both international and domestic markets, aiming to become a leading specialty chemicals manufacturer in China[129]. - Future development plans include the expansion of new projects, with a focus on enhancing production capacity and market reach[145].

Group 1: Core Raw Materials for Special Engineering Plastics - DFBP is a key monomer in the production of PEEK, requiring approximately 0.8 tons of DFBP to produce 1 ton of PEEK [3] - The company has a deep understanding of the PEEK supply chain, leading to higher product purity and recognition from key customers [3] - The advantages of DFBP production include lower material costs, innovative catalyst and purification technologies, and reduced organic solvent usage [3] Group 2: Market and Customer Insights - Direct users of DFBP are primarily PEEK manufacturers with stable and large procurement volumes, while traders use DFBP mainly in the pharmaceutical sector with smaller volumes [4] - The market share of DFBP is not officially documented, with only two main suppliers identified: the company and Yingkou Xingfu [4] Group 3: Light Initiators - The company’s light initiators include MBP, PBZ, and ITF, with specific initiation wavelengths of 245nm, 289nm, and 246/289nm respectively [4] - The product offerings differ from competitors like Jiu Ri and Lian Long, focusing on complementary rather than directly competitive products [4] Group 4: Cosmetic Ingredients - The company is the exclusive supplier of HAP products to SYMRISE in China, with no comparable manufacturers in the domestic market [5] - HAP is industrially produced for cosmetic applications, with the company’s technology ensuring compliance with cosmetic standards [5] Group 5: Future Development Strategies - The company aims to enhance its core capabilities in green production and product quality while expanding its product range and capacity [6] - The long-term goal is to become a leading fine chemical enterprise and a major production base for Friedel-Crafts reactions [6] - Ongoing collaborations with downstream customers and research institutions are intended to explore new applications for core products [6] Group 6: Investment and Capacity Expansion - The company is in the process of installing equipment for an 8000-ton aromatic ketone production facility, with production expected to ramp up gradually [7]

Group 1: Market Overview - The DFBP product is primarily used in the polymerization of PEEK, with a stable competitive landscape currently featuring 2 domestic suppliers and 1 overseas supplier from India [2] - The application fields of PEEK are expanding, including aerospace, automotive manufacturing, IT electronics, healthcare, and 3D printing, driven by trends towards lightweight, energy efficiency, and safety [2][3] - The market demand for PEEK materials is expected to grow rapidly, with major manufacturers like WEG, Solvay, Evonik, and Zhongyan having production capacities in the kiloton range [2][3] Group 2: Company Strategy and Development - The company has a long-term research focus on the PEEK supply chain, with stable quality control and recognition from key customers [3][4] - The company plans to expand its product offerings in the downstream application of PEEK materials, which is a key area of focus [3] - The company is the sole domestic supplier of cosmetic-grade HAP products, with agreements that include minimum purchase quantities and price adjustments based on order cycles and material costs [3][4] Group 3: Production Capacity and Investment Projects - The company is currently working on a fundraising project with an annual production capacity of 8,000 tons of aromatic ketones, which is double the existing capacity [4] - The designed production capacity for DFBP is 2,500 tons/year, and for HAP is 2,000 tons/year, reflecting strong market and customer demand [4] - The company will adjust its product structure based on market demand and the characteristics of new and existing capacities to explore new profit growth points [4]

Group 1: Production Capacity and Market Demand - The company plans to release 2,000 tons of HAP production capacity this year, with strong market demand and signed framework agreements with customers for minimum purchase volumes [3][4] - The first and second workshops for HAP and DFBP have been installed and are undergoing pre-production approvals, with specific timelines dependent on the approval process [3] Group 2: Pricing and Cost Factors - The price of HAP is influenced by supply and demand dynamics rather than solely by rising crude oil prices, as the raw materials are primarily fine chemicals [3][4] - The gross margins for DFBP and photoinitiators remained stable or improved due to consistent sales and demand in the first half of the year [4] Group 3: Competitive Landscape - Currently, there are no domestic manufacturers with comparable market positions for HAP, although a few companies produce HAP primarily for pharmaceutical intermediates [4] Group 4: Future Development Plans - The company aims to explore new product breakthroughs in the cosmetics raw materials sector, leveraging its strengths to enhance its product matrix for formulation companies [4]

Financial Performance - The company's revenue for Q3 2022 was ¥94,504,518.10, representing a 24.92% increase year-over-year[5] - Net profit attributable to shareholders for Q3 2022 was ¥22,056,778.89, a 36.16% increase compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥20,149,282.30, up 34.20% year-over-year[5] - Net profit for Q3 2022 reached ¥71,844,712.48, an increase of 42.18% compared to the same period last year[9] - Earnings per share (EPS) for Q3 2022 was ¥0.69, compared to ¥0.65 in the same quarter last year, indicating a growth of 6.2%[19] Assets and Liabilities - The total assets at the end of Q3 2022 reached ¥1,152,014,690.04, reflecting a 5.31% increase from the end of the previous year[5] - The company’s equity attributable to shareholders rose to ¥1,046,857,303.73, a 3.31% increase from the previous year[5] - The company's total liabilities increased to ¥105,157,386.31 from ¥80,688,240.78, marking a rise of 30.3% year-over-year[18] - Total assets as of September 30, 2022, amounted to ¥1,152,014,690.04, an increase from ¥1,093,960,706.38 at the beginning of the year[14] Cash Flow - The company reported a 62.09% increase in cash flow from operating activities, totaling ¥76,782,633.04 year-to-date[5] - Operating cash flow net amount for the first nine months of 2022 was ¥76,782,633.04, up 62.09% year-on-year[9] - The net cash flow from operating activities for the period was ¥76,782,633.04, an increase of 62.0% compared to ¥47,369,592.68 in the previous period[20] - The net cash flow from investment activities was -¥152,316,384.64, worsening from -¥37,535,148.04 year-over-year[20] - The net cash flow from financing activities was -¥40,032,900.00, a significant decrease compared to a net inflow of ¥616,594,822.86 in the previous period[21] Investment and Expenses - Research and development expenses increased by 59.03% to ¥11,588,137.71, indicating a significant investment in technology development[8] - The company reported an increase in investment income of 136.65% to ¥10,045,875.10 due to increased interest income from financial products[9] - The company reported a significant decrease in financial expenses, with a reduction of 9616.84% to -¥9,378,221.02, primarily due to increased foreign exchange gains[8] - Total operating costs amounted to ¥203,770,178.41, up from ¥182,177,505.31, reflecting a year-over-year increase of 11.5%[18] Inventory and Receivables - The company’s inventory increased by 43.30% to ¥55,938,775.71, attributed to the accumulation of raw materials and finished goods[8] - The company’s accounts receivable increased to ¥75,162,767.58 from ¥62,920,066.24, indicating a growth in sales[15] Other Financial Metrics - The company’s basic earnings per share remained stable at ¥0.21, with a year-to-date figure of ¥0.69, reflecting a 6.15% increase[5] - The company recognized a significant increase in foreign exchange gains due to the rising USD/CNY exchange rate[9] - The balance of cash and cash equivalents at the end of the period was ¥73,477,785.77, down 88.62% from the previous year[9] - The company’s gross profit margin improved, contributing to the overall increase in operating profit[9]

Financial Performance - The company reported a revenue of RMB 500 million for the first half of 2022, representing a year-on-year increase of 15%[1]. - The company's operating revenue for the first half of 2022 was ¥182,788,073.17, representing a 13.62% increase compared to ¥160,879,719.18 in the same period last year[21]. - Net profit attributable to shareholders was ¥49,787,933.59, a 45.02% increase from ¥34,331,196.07 year-on-year[21]. - The total profit for the first half of 2022 was ¥57,573,916.66, an increase of 45.2% from ¥39,677,132.44 in the same period last year[192]. - Future guidance estimates a revenue growth of 12% for the second half of 2022[1]. - The company reported a basic earnings per share of ¥0.48, reflecting a 9.09% increase from ¥0.44 in the previous year[21]. - The basic and diluted earnings per share for the first half of 2022 is CNY 0.48, with a net asset per share of CNY 9.90[169]. Research and Development - The company plans to invest RMB 100 million in R&D for new product development in the next fiscal year[1]. - Research and development expenses increased by 33.16% year-on-year, totaling CNY 6.73 million, indicating a strong commitment to innovation[80]. - The company has established a robust R&D mechanism, collaborating with top universities and research institutions to enhance its innovation capabilities[34]. - Continuous technological innovation has enabled the company to improve product quality and production efficiency, maintaining its competitive edge[70]. Market Strategy and Expansion - The company has outlined a market expansion strategy targeting Southeast Asia, aiming for a 10% market share by 2025[1]. - The company is exploring potential mergers and acquisitions to enhance its market position[1]. - The company plans to increase its annual production capacity to 8,000 tons of aromatic ketones, including 2,500 tons of DFBP, to strengthen its market position[49]. - The demand for PEEK is expected to grow significantly in emerging markets like China and India, driven by its superior properties and applications[47]. Financial Health and Investments - The net cash flow from operating activities surged by 176.85% to ¥56,870,568.12, up from ¥20,542,373.82 in the previous year[21]. - The total investment amount for the reporting period was ¥598,361,984.47, representing a 223.44% increase compared to ¥185,000,000.00 in the same period last year[89]. - The company has committed investments totaling CNY 40,400 million, with a cumulative investment of CNY 30,438 million, representing 75.23% of the planned investment completion[100]. - The company has received multiple certifications and awards, reflecting its technological strength and market influence, including recognition as a high-tech enterprise by Jiangsu Province[69]. Risk Factors - The company faces risks including fluctuations in gross margin and uncertainties due to the COVID-19 pandemic[1]. - Fluctuations in gross margin due to rising raw material costs, particularly influenced by international crude oil prices and environmental policies, pose a risk to profitability[110]. - The company is exposed to foreign exchange risks due to a high proportion of export revenue denominated in USD, which can affect competitiveness and financial performance[112]. - The company faces risks from the ongoing uncertainty caused by the COVID-19 pandemic, which may impact operational performance despite implemented countermeasures[109]. Environmental and Safety Practices - The company emphasizes environmental protection and safety, having never experienced any environmental or safety incidents, and has received multiple awards for its practices[75]. - The company has established an Environmental Protection Department with 6 management personnel and 8 operational staff dedicated to daily environmental management[126]. - The company has implemented a wastewater treatment process that meets discharge standards, with online monitoring devices installed at both wastewater and stormwater discharge points[127]. - The company has a total of 1 wastewater discharge point for COD with a discharge amount of 0.634 tons, which is below the standard of <500 mg/L[124]. Shareholder Relations - The company has actively engaged in protecting the rights of shareholders, particularly minority investors, through transparent communication and information disclosure[132]. - The company has a participation rate of 74.99% in the 2021 annual shareholders' meeting held on May 17, 2022[118]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties during the reporting period[143]. - The report indicates a stable shareholder structure with no significant changes in major ownership percentages during the reporting period[173].

Financial Performance - The company's operating revenue for 2021 was ¥342,031,413.67, representing an increase of 18.80% compared to ¥287,902,279.19 in 2020[17]. - The net profit attributable to shareholders for 2021 was ¥66,294,263.47, a decrease of 7.25% from ¥71,478,301.56 in 2020[17]. - The net profit after deducting non-recurring gains and losses was ¥61,084,689.62, down 9.43% from ¥67,447,666.70 in 2020[17]. - The company's total assets increased by 133.30% to ¥1,093,960,706.38 at the end of 2021, compared to ¥468,899,974.12 at the end of 2020[17]. - The net assets attributable to shareholders rose by 159.17% to ¥1,013,272,465.60 at the end of 2021, up from ¥390,974,847.75 at the end of 2020[17]. - The basic earnings per share for 2021 was ¥1.03, a decrease of 14.17% from ¥1.20 in 2020[17]. - The weighted average return on equity for 2021 was 11.77%, down from 20.17% in 2020, indicating a decline of 8.40%[17]. - The company reported a net cash flow from operating activities of ¥75,560,864.86, an increase of 4.05% from ¥72,622,855.19 in 2020[17]. - In 2021, the company achieved a total revenue of 342.03 million yuan, representing an 18.80% increase compared to the previous year[72]. - The company's operating costs for 2021 were 232.56 million yuan, an increase of 38.06% year-on-year, primarily due to increased sales volume and rising raw material prices[72]. - The net profit for 2021 was 66.29 million yuan, a decrease of 7.25% compared to the previous year, although the decline showed improvement compared to the first three quarters of 2021[72]. Market Position and Strategy - The company is positioned to benefit from national policies supporting the PEEK industry, with increasing demand from emerging markets like China and India[29]. - The company has established long-term partnerships with major global PEEK manufacturers, enhancing its market competitiveness and bargaining power[32]. - The company has developed high-tech products like ITF, which reduce volatile emissions and expand applications in food packaging[39]. - The company is focused on expanding its market presence and enhancing its product offerings through ongoing research and development initiatives[153]. - Jiangsu Xinhang aims to leverage its experienced management team, which includes professionals with extensive backgrounds in chemical engineering and production management, to drive future growth[154]. - The company plans to explore potential mergers and acquisitions to further enhance its market position and expand its product portfolio[153]. - Jiangsu Xinhang's strategic focus includes the development of new technologies to meet evolving market demands and customer needs[153]. - The company is actively monitoring market trends to identify opportunities for growth and expansion in both domestic and international markets[156]. Research and Development - The company has established a strong independent R&D system and collaborates with top universities and research institutions, enhancing its continuous innovation capabilities[55]. - The company has increased its R&D investment to enhance existing product processes and develop new products with market potential[117]. - The company is currently in the small trial stage for several R&D projects aimed at developing new products and improving environmental sustainability[86]. - The company has allocated 100 million yuan for R&D in advanced materials technology, aiming to enhance product performance and sustainability[162]. Risk Management - The company highlighted risks including uncertainties from the COVID-19 pandemic, fluctuations in gross margin, and potential delays in new projects generating benefits[4]. - The company has acknowledged the need for investors to be aware of the differences between plans, forecasts, and commitments, highlighting the importance of risk awareness[4]. - The company has implemented a comprehensive risk management strategy to address uncertainties related to the COVID-19 pandemic and market competition[124]. - The company has a clear risk assessment strategy to identify and manage potential internal and external risks[193]. Corporate Governance - The company held seven board meetings during the reporting period, adhering strictly to relevant laws and regulations[134]. - The company conducted five supervisory board meetings, ensuring compliance and protecting the rights of shareholders[135]. - The company maintains independence from its controlling shareholder in terms of assets, personnel, finance, organization, and business operations[139]. - The company has established an independent financial accounting system and does not share bank accounts with its controlling shareholder[142]. - The company has established a transparent information disclosure system, ensuring equal access to information for all shareholders[137]. - The board of directors is responsible for information disclosure, with the chairman being the primary responsible person[198]. Production and Operations - The company has a designed capacity of 8,000 tons per year for aromatic ketone products, with an actual utilization rate of 105.1%[62]. - The company has developed proprietary technologies and holds 9 patents, including 4 invention patents, enhancing its competitive edge in the aromatic ketone sector[62]. - The company has a flexible production arrangement that allows it to adapt to customer orders and reduce dependency on specific downstream industries[68]. - The company maintains a quality management system throughout the production process, with multiple inspections of raw materials and finished products to ensure high quality[58]. - The company has implemented various internal control measures across procurement, production, sales, and financial management to enhance operational efficiency[197]. Employee Management - The company has a total of 256 employees, with 181 in production roles and 35 in technical positions[180]. - The educational background of employees includes 2 with master's degrees, 29 with bachelor's degrees, and 41 with associate degrees[181]. - The company has established a comprehensive and fair compensation management system to align employee interests with corporate goals[182]. - Training programs are in place to enhance employee skills and improve overall productivity, including a system for cultivating university graduates[183]. Financial Management - The company has a total of CNY 30,842,040 in unused raised funds, which are stored in a dedicated account for cash management[105]. - The company has implemented a cash management plan using idle funds for investment projects[177]. - The company plans to utilize part of the idle raised funds and self-owned funds for cash management[150]. - The company has a remaining balance of CNY 2,988.37 million in its fundraising account, with CNY 28,000 million temporarily idle for cash management[109]. Profit Distribution - The company reported a profit distribution plan of 5.00 RMB per 10 shares (including tax) and a capital reserve increase of 3 shares for every 10 shares held[4]. - The company plans to distribute a cash dividend of 5 RMB per 10 shares, totaling 39,800,000 RMB, which represents 100% of the distributable profit[185]. - The distributable profit for the year is reported at 273,025,732.02 RMB, with no other forms of cash distribution[185].